HOME >> BIOLOGY >> NEWS
American Chemical Society's Weekly PressPac -- June 20, 2007

showed that red and white wine were effective in controlling the growth of several strains of streptococci bacteria that are involved in tooth decay, and some cases of sore throat. Overall, our findings seem to indicate that wine can act as an effective antimicrobial agent against the tested pathogenic oral streptococci and might be active in caries and upper respiratory tract pathologies prevention, the study states, noting that tests now are underway to determine wines effects on those diseases in humans.

ARTICLE #3 FOR IMMEDIATE RELEASE
Antibacterial Activity of Red and White Wine Against Oral Streptococci

DOWNLOAD PDF
http://pubs.acs.org/cgi-bin/sample.cgi/jafcau/asap/pdf/jf070352q.pdf

DOWNLOAD HTML
http://pubs.acs.org/cgi-bin/sample.cgi/jafcau/asap/html/jf070352q.html

CONTACT:
Gabriella Gazzani, Ph.D.
University of Pavia
Pavia, Italy
Phone: 39-0382-987-373
Fax: 39-0382-422-975
Email: gabriella.gazzani@unipv.it


ARTICLE #4 FOR IMMEDIATE RELEASE

New study supports stopping and restarting school buses to cut emissions
Environmental Science & Technology

New evidence reported in ACSs Environmental Science & Technology (ES&T) suggests that anti-idling advocates are on the right track in an ongoing debate over exhaust emissions from school buses.

In a study scheduled for the July 15 issue of ES&T, a semi-monthly journal, the U. S. Environmental Protection Agencys John S. Kinsey and colleagues note that regulatory agencies and school districts have issued guidance or regulations limiting the idling of school buses while students are getting on and off. Those actions resulted from studies of
'"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
25-Jun-2007


Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
3. American Chemical Society meets Aug. 19-23 in Boston
4. American Chemical Societys Weekly PressPac -- Aug. 1, 2007
5. American buffalo slaughter fueled by international trade
6. American Chemical Societys Weekly PressPac -- July 25, 2007
7. American Chemical Societys Weekly PressPac -- July 18, 2007
8. American Chemical Societys Weekly PressPac -- July 11, 2007
9. Tips from the Journals of the American Society for Microbiology
10. Wiley extends publishing partnership with the American Institute of Chemical Engineers
11. Highlights from the July 2007 Journal of the American Dietetic Association

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: American Chemical Society Weekly PressPac June

(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
(Date:5/11/2015)... DAYTON, Ohio , May 11, 2015  Through a ... Ohio had a strong showing at AUVSI,s ... . These representatives of Ohio,s UAS ... domestic and abroad from all points along the UAS ecosystem. ... Dayton Development Coalition,s (DDC) Vice President for Aerospace Rich ...
(Date:5/8/2015)... May 8, 2015 Synaptics Inc. (NASDAQ: SYNA ... that members of the executive management team will present at ... Technology, Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company ... 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2
(Date:5/21/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... develops and commercializes proprietary technologies and products for advanced ... for the second fiscal quarter ended March 31, 2015. ... to advance business with our existing customers and to ... and CEO of SQI. "The delivery of a fully ...
(Date:5/21/2015)... San Francisco, CA (PRWEB) May 21, 2015 ... microbiome sequencing, has announced a partnership with PicnicHealth, ... records for patients. Participants diagnosed with Inflammatory Bowel ... as well as a complementary uBiome research kit. ... Summer 2014. , For more ...
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2
Cached News: